Kopran Limited

NSE:KOPRAN India Drug Manufacturers - General
Market Cap
$68.03 Million
₹5.89 Billion INR
Market Cap Rank
#22984 Global
#1192 in India
Share Price
₹122.01
Change (1 day)
-1.66%
52-Week Range
₹121.04 - ₹205.85
All Time High
₹350.00
About

Kopran Limited, an integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides d… Read more

Kopran Limited (KOPRAN) - Total Liabilities

Latest total liabilities as of September 2025: ₹3.12 Billion INR

Based on the latest financial reports, Kopran Limited (KOPRAN) has total liabilities worth ₹3.12 Billion INR as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Kopran Limited - Total Liabilities Trend (2004–2025)

This chart illustrates how Kopran Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Kopran Limited Competitors by Total Liabilities

The table below lists competitors of Kopran Limited ranked by their total liabilities.

Company Country Total Liabilities
Hancock & Gore Ltd
AU:HNG
Australia AU$28.02 Million
SVB & T Corp
OTCQX:SVBT
USA $564.49 Million
InspireMD Inc
NASDAQ:NSPR
USA $14.36 Million
IX Acquisition Corp
NASDAQ:IXAQ
USA $13.70 Million
Kyongbo Pharmaceutical Co Ltd
KO:214390
Korea ₩171.21 Billion
Tobii AB (publ)
F:24T
Germany €900.00 Million
Tristar Gold
OTCQB:TSGZF
USA $2.60 Million

Liability Composition Analysis (2004–2025)

This chart breaks down Kopran Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.63 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.14 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.62 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.38 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Kopran Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Kopran Limited (2004–2025)

The table below shows the annual total liabilities of Kopran Limited from 2004 to 2025.

Year Total Liabilities Change
2025-03-31 ₹3.26 Billion +29.23%
2024-03-31 ₹2.52 Billion +19.74%
2023-03-31 ₹2.10 Billion +13.93%
2022-03-31 ₹1.85 Billion -4.96%
2021-03-31 ₹1.94 Billion +6.92%
2020-03-31 ₹1.82 Billion -1.13%
2019-03-31 ₹1.84 Billion +7.67%
2018-03-31 ₹1.71 Billion +3.32%
2017-03-31 ₹1.65 Billion +6.56%
2016-03-31 ₹1.55 Billion -12.15%
2015-03-31 ₹1.77 Billion -4.31%
2014-03-31 ₹1.84 Billion +11.07%
2013-03-31 ₹1.66 Billion +1.00%
2012-03-31 ₹1.64 Billion +8.37%
2011-03-31 ₹1.52 Billion -5.12%
2010-03-31 ₹1.60 Billion -6.18%
2009-03-31 ₹1.70 Billion -14.00%
2008-03-31 ₹1.98 Billion -38.57%
2007-03-31 ₹3.23 Billion -6.01%
2006-03-31 ₹3.43 Billion -2.86%
2005-03-31 ₹3.53 Billion +12.96%
2004-03-31 ₹3.13 Billion --